Audited Results of Hester Biosciences Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	286.47	285.15	254	219.35	208.48
Manufacturing Expenses	10.12	12.34	9.95	8.74	6.93
Personnel Expenses	54.76	56.72	47.92	39.12	33.45
Selling Expenses	0	0	0	0	0
Administrative Expenses	69.11	60.21	57.62	46.11	40.12
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	235.52	237.81	199.11	158.78	136.48
Operating Profit	50.94	47.34	54.89	60.57	71.99
Other Recurring Income	4.76	4.26	5.32	4.66	1.65
Adjusted PBDIT	55.71	51.60	60.21	65.23	73.64
Financial Expenses	5.37	5.09	6.50	2.47	3.95
Depreciation	8.58	9.78	9.79	9.50	9.63
Other Write offs	0	0	0	0	0
Adjusted PBT	41.76	36.73	43.92	53.26	60.06
Tax Charges	9.92	9.57	11.58	13.74	14.88
Adjusted PAT	31.84	27.16	32.34	39.52	45.18
Non Recurring Items	-0.36	-0.02	0.11	-0.16	-5.06
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	31.84	27.16	32.34	39.52	39.90
Equity Dividend	5.10	6.80	8.51	8.51	5.62
Preference Dividend	0	0	0	0	0
Retained Earnings	272.90	246.53	226.20	202.25	171.40

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article